StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) income statement

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.06−0.38 (-5.11%)

Close on Nov 20, 2026Market cap $424.23MP/E –Yield –

See a number that looks wrong?